You're staring at the HESI case study screen. Patient: M.G., 68-year-old male. History: hypertension, type 2 diabetes, now stage 4 chronic kidney disease. Also, labs everywhere. Meds to reconcile. Questions piling up.
Your heart rate ticks up. But HESI doesn't test knowledge — it tests clinical judgment. You know CKD pathophysiology. You know the meds. And that's a different beast entirely.
Here's what nobody tells you in lecture: the HESI CKD case study isn't about memorizing GFR stages. Still, it's about recognizing the cascade. The way one abnormal value pulls three others with it. Still, the way a "routine" medication becomes dangerous when creatinine clearance drops below 30. The way fluid overload hides behind "stable" vitals until it doesn't No workaround needed..
Let's walk through it like you're precepting a new grad. Real talk. No fluff.
What Is the HESI Chronic Kidney Disease Case Study
HESI case studies are simulated patient scenarios designed to measure clinical decision-making. The CKD module typically presents a patient with progressive renal impairment — often complicated by diabetes, hypertension, or both — and asks you to prioritize assessments, interpret trends, select interventions, and evaluate outcomes Nothing fancy..
You'll see tabs: History, Labs, Medications, Orders, Nursing Notes. Even so, you'll click through. You'll answer multiple-choice, select-all-that-apply, and prioritization questions. Some are scored. Some are "practice" but structured identically The details matter here..
The CKD case study usually spans multiple encounters — outpatient clinic, ER admission, dialysis initiation, maybe a post-dialysis complication. Each encounter builds on the last. Miss a trend in encounter two, and encounter three's "priority action" question will eat your lunch The details matter here..
Easier said than done, but still worth knowing.
It's Not a Pathophysiology Quiz
You won't be asked "What is the GFR range for stage 3b CKD?" You will be asked: "The patient's potassium is 5.On the flip side, 8 mEq/L. Now, his current medications include lisinopril, spironolactone, and metformin. Which medication should the nurse question first?
See the difference? One tests recall. The other tests synthesis Nothing fancy..
Why This Case Study Trips Up So Many Students
Most nursing students walk in knowing the what. Far fewer grasp the so what and now what.
CKD is a systems disease. It touches electrolytes, acid-base, fluid balance, hematopoiesis, bone metabolism, medication clearance, nutrition, cardiovascular risk. HESI exploits the connections. A question about anemia isn't really about anemia — it's about erythropoietin deficiency and iron stores and blood loss from frequent draws and the fact that the patient just started hemodialysis and needs heparin.
And the timeline matters. " That's acute on chronic. In real terms, a patient with a creatinine of 2. 1 mg/dL three months ago and 3.8 mg/dL today? In real terms, that's not "chronic. The interventions change completely Took long enough..
The Hidden Trap: "Stable" Doesn't Mean Safe
HESI loves a patient who "denies shortness of breath" but has crackles to the mid-lung fields, +2 edema, and a 3 kg weight gain in 48 hours. Students see "denies SOB" and move on. The nurse sees impending pulmonary edema.
That's the judgment gap. And it's exactly what this case study measures.
How the HESI CKD Case Study Works
You'll typically move through four to six tabs per encounter. The medication reconciliation tab holds the key to half the safety questions. Don't skip tabs. Which means ever. The nursing notes tab often contains the only mention of a missed dialysis session or a new onset of confusion That's the whole idea..
Encounter 1: Outpatient Clinic — The "Routine" Visit That Isn't
Typical presentation: M.G., 68M, T2DM x 15 years, HTN x 20 years. Referred for nephrology follow-up. Reports fatigue, "foamy urine," occasional nocturia x 3. BP 158/94. Weight up 2 kg from last visit.
Labs you'll see:
- Creatinine: 3.2 mg/dL (baseline 2.4 three months ago)
- eGFR: 22 mL/min/1.73m²
- BUN: 58 mg/dL
- K⁺: 5.1 mEq/L
- HCO₃⁻: 19 mEq/L
- Hgb: 9.8 g/dL
- Ca²⁺: 8.6 mg/dL
- Phos: 5.8 mg/dL
- PTH: 185 pg/mL
- UACR: 420 mg/g
Med list: Metformin 1000 mg BID, Lisinopril 40 mg daily, Amlodipine 10 mg daily, Furosemide 40 mg daily, Spironolactone 25 mg daily, Atorvastatin 40 mg nightly, Aspirin 81 mg daily, Insulin glargine 30 units nightly, Insulin lispro sliding scale Turns out it matters..
Questions love to ask:
- Which medication requires immediate dose adjustment or discontinuation?
- What is the priority nursing assessment?
- Which lab value warrants immediate provider notification?
- Select all appropriate patient education topics.
The Metformin Trap
Metformin is contraindicated when eGFR < 30. ** But HESI will dangle distractors: "Hold the lisinopril because potassium is 5.This patient is at 22. **Stop it.1" (no — ACEi is renal protective in diabetic CKD, monitor K⁺), "Discontinue spironolactone" (yes, but metformin is the immediate safety issue — lactic acidosis risk), "Reduce furosemide" (maybe later, not first).
Rule of thumb: Metformin + eGFR < 30 = hard stop. Every time.
The Spironolactone Problem
Potassium 5.Spironolactone should be questioned. But it's not the most urgent. 1 + ACEi + K⁺-sparing diuretic + CKD stage 4 = hyperkalemia waiting to happen. HESI wants you to prioritize life-threatening risk (lactic acidosis from metformin) over evolving risk (hyperkalemia from spironolactone) Still holds up..
The Anemia Workup
Hgb 9.On the flip side, 8. Think about it: don't just say "administer epoetin alfa. " HESI will ask: **What do you assess first?Think about it: ** Iron studies. That said, tSAT. Think about it: ferritin. You don't stimulate erythropoiesis without substrate. And you don't give IV iron without knowing if it's actually iron deficiency vs. In practice, anemia of chronic disease vs. blood loss That's the part that actually makes a difference. Simple as that..
The Bone-Mineral Mess
Ca 8.Think about it: 6, Phos 5. 8, PTH 185. Now, this is secondary hyperparathyroidism from phosphate retention and low calcitriol. Phosphate binders with meals. Practically speaking, calcitriol or cinacalcet maybe. But first — dietary phosphate restriction education. HESI loves asking what to teach before the prescription.
Encounter 2: ER Admission — Fluid Overload & Uremia
Scenario: M.G. presents 3 weeks later. Dyspnea at rest, orthopnea, confusion per daughter. Missed last dialysis appointment (he wasn't on dialysis yet — wait, what?). Oh — he was supposed to start. Didn't show.
Vitals: BP 198/104, HR 102,
Vitals: BP 198/104, HR 102, RR 28, SpO₂ 89% on RA, Temp 37.0°C.
Exam: JVD to angle of jaw supine, bilateral crackles to mid-lung fields, 3+ pitting edema to thighs, cool extremities, difficult to arouse but orientable to name only.
Labs (STAT): K⁺ 6.8 mEq/L, HCO₃⁻ 12 mEq/L, BUN 112 mg/dL, Cr 6.8 mg/dL, Troponin 0.12 ng/mL (chronic elevation), BNP 2,400 pg/mL. CXR: Vascular congestion, bilateral pleural effusions, cardiomegaly.
The "Missed Dialysis" Red Herring
Stop. * He was supposed to start but didn't show for access placement/scheduling. This is de novo uremic crisis with pulmonary edema and life-threatening hyperkalemia — not a "missed run" volume overload. *He wasn't on dialysis yet.Reread the stem. The management algorithm is different.
Priority 1: Airway & Breathing. SpO₂ 89%, RR 28, crackles, orthopnea. High-flow nasal cannula or BiPAP immediately. Do not pass go, do not give IV Lasix yet (renal perfusion is nil; diuretics won't work and drop preload dangerously). Preload reduction via upright positioning + nitroglycerin drip (if SBP > 160) is the bridge The details matter here..
Priority 2: K⁺ 6.8 = Cardiac Arrest Risk.
Peaked T-waves? Wide QRS? Sine wave? Get a 12-lead now.
Simultaneous orders (do not sequence these — fire together):
- Calcium gluconate 1g IV push (cardioprotection — membrane stabilizer, does not lower K⁺).
- Insulin 10 units IV + D50 25g IV (drives K⁺ intracellular — onset 15 min, duration 4–6 hrs).
- Albuterol 10–20 mg neb (adjunct shift — beta-2 agonist).
- Sodium bicarbonate 150 mEq IV (corrects acidosis + shifts K⁺ — this patient has HCO₃⁻ 12, so it’s indicated).
- Kayexalate / Patiromer / Lokelma (binding — slow, for sustained lowering; not for acute crisis).
HESI Trap: "Give furosemide 80 mg IVP." Wrong. eGFR ~10, anuric/oliguric likely. Loop diuretics are nephrotoxic at high doses in this setting and won't produce urine. They cause ototoxicity. Dialysis is the only definitive K⁺/volume/acid clearance.
Priority 3: Emergent Dialysis Access.
Nephrology consult stat. Tunneled catheter (Permcath) > Non-tunneled femoral/IJ. He needs sustained renal replacement therapy (SLED/CRRT) given hemodynamic lability (BP lability, confusion), not intermittent HD (intradialytic hypotension risk). Consent for catheter placement — daughter is surrogate if he’s encephalopathic Simple, but easy to overlook..
The Uremic Encephalopathy & Pericarditis Watch
Confusion + asterixis (check for it) + BUN > 100 = **uremic encephalopathy.Here's the thing — ** Dialysis corrects this. But: Dialysis Disequilibrium Syndrome (DDS) risk is high (first run, severe azotemia).
And Orders for first session:
- Low blood flow (200–250 mL/min)
- Short duration (2–3 hrs)
- Low dialysate flow
- High sodium dialysate (145–150 mEq/L)
- Mannitol 0. Consider this: 5 g/kg or hypertonic saline bolus during treatment if neurologic decline. On the flip side, - **Mannitol/Furosemide pre-HD? ** Only if volume overloaded and making urine. This guy is oliguric.
